Programme: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Room 1 - Main Arena 1

22 events

Tuesday, January 26th: 8:00 - 9:30, Room 1 - Main Arena 1

Symposium: Treatment strategies for complex disease in the SFA/Pop

supported with an educational grant from Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Ramon Varcoe, Brian DeRubertis, Gary Ansel, Lawrence Garcia, Jihad Mustapha, Thomas Zeller
1. 08:00 - 08:08
  
  Introduction by the moderator and overview of complex SFA disease: calcium, long lesions, reintervention
2. 08:08 - 08:16
  
  Treatment strategies for calcium
3. 08:16 - 08:24
  
  Treatment strategies for long lesions > 20 cm
4. 08:24 - 08:44
  
  Live case transmission from Leipzig
5. 08:44 - 08:52
  
  SUPERSUB: Results of subintimal SUPERA cohort in CLI patients
6. 08:52 - 09:00
  
  Economic fempop treatment depends on device choice
7. 09:00 - 09:08
  
  Treatment strategies for reintervention (catastrophic failure)
8. 09:08 - 09:30
  
  Live case transmission from Leipzig
Tuesday, January 26th: 9:30 - 11:00, Room 1 - Main Arena 1

Changing paradigms and future concepts in peripheral interventions – how far have we come?

Moderator:

Dierk Scheinert, Ramon Varcoe

Panel:

Christopher Owens, Jihad Mustapha, Erich Minar, Thomas Zeller, Ayman Al-Sibaie
1. 09:30 - 09:55
  
  DRUG-COATED BALLOONS: LATEST DATA FROM CLINICAL TRAILS
2. 09:30 - 09:35
  
  Angiographic and clinical 6 months results of the CONSEQUENT trial
3. 09:35 - 09:40
  
  AcoArt Trial – 12 months results with the Orchid DEB in femoropoliteal lesions
4. 09:40 - 09:45
  
  Latest insights from the LEVANT II study and subgroup analysis
5. 09:45 - 09:50
  
  IN.PACT SFA trial – 2 year outcomes
6. 09:50 - 09:55
  
  Update on the German/US budget impact model on the cost-effectiveness of DCB in the German & US healthcare systems
7. 09:55 - 10:10
  
  DRUG-COATED BALLOONS: ALSO THE PRIMARY SOLUTION FOR LONG LESIONS?
8. 09:55 - 10:00
  
  Drug-coated balloons: Also the primary solution for long lesions? Pro:
9. 10:00 - 10:05
  
  Drug-coated balloons: Also the primary solution for long lesions? Contra:
10. 10:05 - 10:10
  
  Panel discussion
11. 10:10 - 10:40
  
  ADJUNCTIVE TREATMENT MODALITIES FOR COMPLEX LESIONS
12. 10:10 - 10:15
  
  From pre-dilatation to debulking: what, when and why to add more upon plain DCB
13. 10:15 - 10:35
  
  Live case transmission from Leipzig
14. 10:35 - 10:40
  
  When DCB is not enough: Is there a need for new DAART study?
15. 10:40 - 10:45
  
  FUTURE CONCEPTS FOR DRUG DELIVERY
16. 10:40 - 10:45
  
  DANCE trial
17. 10:45 - 11:00
  
  THE LATEST IN IMPLANT TECHNOLOGY
18. 10:45 - 10:50
  
  Eluvia 12 months data
19. 10:50 - 10:55
  
  RAPID trial: A RCT comparing legflow DCB versus POBA followed by SUPERA stenting in “real world” long-segment femoropopliteal lesions
20. 10:55 - 11:00
  
  Discussion
Tuesday, January 26th: 11:00 - 12:30, Room 1 - Main Arena 1

Symposium: Drug elution – leave the right thing behind. Debating evidence to provide the answers.

supported with an educational grant from Cook Medical

Moderator:

Michael Dake

Panel:

Francesco Liistro, Gary Ansel, Andrew Holden
1. 11:00 - 11:05
  
  Introduction by the moderator
2. 11:05 - 11:12
  
  Why my stent usage is increasing
3. 11:12 - 11:20
  
  Surgical bypass or Zilver PTX – 12-month preliminary data
4. 11:20 - 11:45
  
  Live case transmission from Leipzig
5. 11:45 - 11:53
  
  Leave the right thing behind - patterns of restenosis
6. 11:53 - 12:15
  
  Live case transmission from Dendermonde
7. 12:15 - 12:23
  
  An evidence based approach: Bare stents and balloons are obsolete
8. 12:23 - 12:30
  
  Summary of the symposium, discussion and questions
Tuesday, January 26th: 12:30 - 13:30, Room 1 - Main Arena 1

Lunch
Tuesday, January 26th: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: From simple to complex lesions: Is the robust IN.PACT DCB evidence shifting the SFA treatment paradigm?

supported with an educational grant from Medtronic

Moderator:

Thomas Zeller, Marianne Brodmann

Panel:

Peter Schneider, Gary Ansel, Robert Melder, Fabrizio Fanelli
1. 13:30 - 13:38
  
  Deep dive: IN.PACT SFA 2 year outcomes
2. 13:38 - 13:46
  
  A real-world experience: 12-month outcomes from IN.PACT Global Long Lesions imaging cohort
3. 13:46 - 14:11
  
  Live case transmission from Cotignola
4. 14:11 - 14:19
  
  The vexing problem of ISR: Is IN.PACT DCB the solution? 12 months outcomes from IN.PACTGlobal study ISR imaging cohort
5. 14:19 - 14:27
  
  Understanding the science behind the latest evidence
6. 14:27 - 14:35
  
  How IN.PACT DCB evidence has changed my SFA treatment algorithm
7. 14:35 - 15:00
  
  Live case transmission from Leipzig
Tuesday, January 26th: 15:00 - 16:30, Room 1 - Main Arena 1

Controversial issues, new insights and pioneering solution for Critical Limb Ischemia

Moderator:

Dierk Scheinert, Peter Schneider

Panel:

Ramon Varcoe, George Adams, Mohammad AlTwalah, Sebastian Debus, Steven Kum
1. 15:00 - 15:05
  
  First-line treatment strategies in patients with critical limb ischemia: One year outcomes from the CRITISCH registry
2. 15:05 - 15:12
  
  Explaining the discrepancy between low patency and higher limb salvage rates after revascularization for CLI: Does perfusion matter or not?
3. 15:12 - 16:30
  
  CLINICAL TRAIL UPDATE
4. 15:12 - 15:17
  
  The 3 year outcomes of endoluminal bypass for patients with CLI: The Spanish experience
5. 15:17 - 15:22
  
  The NANOCROSS study: final 12 month results
6. 15:22 - 15:27
  
  1-year results of the PES-BTK-70 study: investigating a self-expanding paclitaxel-eluting stent in BTK arteries
7. 15:27 - 15:32
  
  12 months results of the PREVENT study: investigating the Everolimus-eluting stent in BTK lesions in CLI patients
8. 15:32 - 15:56
  
  Live case transmission from Leipzig
9. 15:56 - 16:03
  
  Calcification of BTK arteries: The scope of the problem and attempts to solve it
10. 16:03 - 16:10
  
  Bioabsorbable drug-eluting scaffolds in BTK arteries: Update on the ABSORB BTK project
11. 16:10 - 16:15
  
  Future concepts for drug delivery
12. 16:15 - 16:20
  
  The LIMBO project: Micropuncture mediated adventitial drug infusion to prevent restenosis in BTK arteries
13. 16:20 - 16:25
  
  Tack optimized balloon angioplasty below the knee (TOBA-BTK) 6 months results: A new method for treating CLI patients with post-PTA dissections
14. 16:25 - 16:30
  
  Remaining challenges and future concepts: Will drug-eluting balloons ever work in BTK arteries? - R. Virmani
Tuesday, January 26th: 16:30 - 18:00, Room 1 - Main Arena 1

The last frontiers: Calcified lesions

Moderator:

Gary Ansel, Marianne Brodmann

Panel:

Andrew Holden, Ayman Al-Sibaie, Craig Walker, Jean-Paul de Vries, Spiridon Botsios, Ammanulla Bolia
1. 16:30 - 16:37
  
  Patterns of vessel calcification and clinical relevance
2. 16:37 - 16:44
  
  Crossing techniques for calcified CTOs
3. 16:44 - 17:10
  
  Live case transmission from New York
4. 17:10 - 18:00
  
  WHAT IS THE BEST CONCEPT TO DEAL WITH SEVERE CALCIFICATION?
5. 17:10 - 17:15
  
  Remove it! – Update on atherectomy techniques for calcified lesions
6. 17:15 - 17:20
  
  Just stent it! – Biomimetic interwoven stents
7. 17:20 - 17:25
  
  Disrupt it! – The Shockwave lithotrypsie concept
8. 17:25 - 17:30
  
  Go around it! – The percutaneous bypass technique
9. 17:30 - 17:40
  
  Recorded case: Shockwave lithotrypsie
10. 17:40 - 18:00
  
  Live case transmission from Leipzig
Wednesday, January 27th: 8:00 - 9:30, Room 1 - Main Arena 1

Symposium: The evolution of peripheral arterial interventions and the revolution in drug eluting technologies

supported with an educational grant from Boston Scientific

Moderator:

Dierk Scheinert

Panel:

Michael Lichtenberg, Nicolas Shammas, Jaydeep Kokate, Thomas Zeller
1. 08:00 - 08:03
  
  Introduction by the moderator
2. 08:03 - 08:16
  
  State of play – contemporary use of DCB and Ranger Investigator Sponsored Research
3. 08:16 - 08:29
  
  Hello again – re-intervention strategies for sub-optimal results of current technologies
4. 08:29 - 09:00
  
  Live case transmission from Berlin
5. 09:00 - 09:13
  
  Eluvia – designing a revolutionary drug eluting stent for SFA intervention
6. 09:13 - 09:26
  
  Setting a new benchmark – Eluvia clinical results and ongoing studies
7. 09:26 - 09:30
  
  Conclusion by the moderator
Wednesday, January 27th: 9:30 - 11:00, Room 1 - Main Arena 1

Venous interventions: Current status and open questions

Moderator:

Gary Ansel, Iris Baumgartner

Panel:

Michael Jaff, Rupert Bauersachs, Michael Lichtenberg, Cees Wittens, William Gray, Ralf Kolvenbach
1. 09:30 - 09:37
  
  Intervention for DVT and PE – a revolution in the making
2. 09:37 - 09:44
  
  Status of anticoagulation therapy in 2016: Is there a need for venous revascularization?
3. 09:44 - 09:51
  
  Current evidence for deep venous interventions
4. 09:51 - 10:21
  
  Live case transmission from Berne
5. 10:21 - 10:28
  
  Techniques for thrombus removal in acute DVT
6. 10:28 - 10:35
  
  Interventions in the chronic setting with post-thrombotic syndrome
7. 10:35 - 10:42
  
  Thrombus removal in acute pulmonary embolism – when and how?
8. 10:42 - 10:47
  
  Innovative endovascular approach to pulmonary embolism by ultrasound enhanced thrombolysis
9. 10:47 - 10:54
  
  Endovenous interventions for varicose vein disease – current status
10. 10:54 - 11:00
  
  Discussion
Wednesday, January 27th: 11:00 - 12:30, Room 1 - Main Arena 1

Symposium: How to treat complex peripheral lesions with confidence

supported with an educational grant from Gore & Associates

Moderator:

Daniele Savio

Panel:

Michel Reijnen, Peter Soukas, Fabien Thaveau, Jeffrey Y. Wang, Darren Schneider
1. 11:00 - 11:05
  
  Introduction by the moderator
2. 11:05 - 11:20
  
  Treating challenging lesions: the importance of flexibility and accuracy
3. 11:20 - 11:35
  
  Live case transmission from Leipzig
4. 11:35 - 11:50
  
  In-stent restenosis: What is the impact of reintervention? What is the choice of therapy costing you?
5. 11:50 - 12:10
  
  Live case transmission from Dendermonde
6. 12:10 - 12:20
  
  Lessons learnt when treating complex lesions using an endoluminal bypass
7. 12:20 - 12:30
  
  Discussion and conclusion by the moderator
Wednesday, January 27th: 12:35 - 13:20, Room 1 - Main Arena 1

Latest pharmacological innovations for peripheral arterial disease: How to optimize the outcome of peripheral revascularization?

Moderator:

Dierk Scheinert

Panel:

Michael Jaff, Frans Moll, Rupert Bauersachs, Marco Roffi, Dariusz Dudek
1. 12:35 - 12:40
  
  Introduction by the moderator
2. 12:40 - 12:50
  
  What is best medical therapy in PAOD and is there a need for better concepts and more data?
3. 12:50 - 13:00
  
  The EPAD-Study: RCT comparing endoxaban and aspirin to clopidogrel and aspirin in SFA and proximal popliteal interventions
4. 13:00 - 13:10
  
  The VOYAGER trial: RCT investigating the efficacy and safety of rivaroxaban to reduce the risk of major thrombotic vascular events in patients with symptomatic PAOD undergoing revascularization
5. 13:10 - 13:20
  
  Discussion and conclusion
Wednesday, January 27th: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: LUTONIX® DCB – clinical evidence and real life experiences in SFA, BTK & AV indications

supported with an educational grant from C. R. Bard

Moderator:

Dierk Scheinert

Panel:

Fabrizio Fanelli, Sabine Steiner
1. 13:30 - 13:37
  
  A study of downstream events of the two leading DCBs on the market - R. Virmani
2. 13:37 - 13:44
  
  LUTONIX® DCB in SFA – insights of the LEVANT 2 & real world outcomes from the global registry
3. 13:44 - 13:53
  
  LUTONIX® DCB in SFA – insights of the LEVANT 2 German cohort
4. 13:53 - 14:39
  
  Live case transmission from Leipzig
5. 14:39 - 14:46
  
  LUTONIX® DCB in BTK – Update on the BTK clinical program & single center experience
6. 14:46 - 14:53
  
  LUTONIX® DCB in AV access – a single center experience
7. 14:53 - 15:00
  
  LUTONIX® DCB in AV access – a single center experience
Wednesday, January 27th: 15:00 - 16:30, Room 1 - Main Arena 1

VIVA @ LINC: Next steps in carotid revascularization

Moderator:

Peter Schneider

Panel:

William Gray, Sean Lyden, Kenneth Rosenfield, Raghu Kolluri
1. 15:00 - 15:05
  
  Announcement of the Vascular Career Advancement Award Recipients: R. Kolluri, Th. Bisdas
2. 15:05 - 15:13
  
  How should studies be designed to evaluate new carotid protection devices and stents?
3. 15:13 - 15:39
  
  Live case transmission from Kingsport
4. 15:39 - 15:47
  
  Is proximal protection the way forward? Options, techniques and results
5. 15:47 - 15:55
  
  Will mesh covered stents help reduce the risk of stroke?
6. 15:55 - 16:22
  
  Live case transmission from Kingsport
7. 16:22 - 16:30
  
  Carotid revascularization 20 years from now
Wednesday, January 27th: 16:30 - 18:00, Room 1 - Main Arena 1

The last frontiers: In-stent restenosis, popliteal and long lesions

Moderator:

Patrick Peeters, William Gray

Panel:

Hans Krankenberg, Peter Schneider, Roberto Ferraresi, Klaus Amendt, Johannes Lammer
1. 16:30 - 16:45
  
  DEBATE: MECHANICAL BARRIER VS. DRUG-ELUTION FOR TREATMENT OF IN-STENT RESTENOSIS
2. 16:30 - 16:35
  
  Pro drug-elution
3. 16:35 - 16:40
  
  Pro mechanical barrier
4. 16:40 - 16:45
  
  The Lutonix global drug coated balloon registry: 12 months results of the ISR subgroup
5. 16:45 - 16:50
  
  Biology of in-stent restenosis and rational for debulking
6. 16:50 - 17:10
  
  Live case transmission from Leipzig
7. 17:10 - 17:15
  
  Is flexed knee study useful in popliteal artery angioplasty?
8. 17:15 - 17:20
  
  Spot-stenting – Multi-LOC theoretical background and first real world results
9. 17:20 - 17:25
  
  Initial results of the ZILVERPASS study: A RCT investigating the Zilver PTX DES vs. bypass surgery for femoropopliteal TASC C&D lesions
10. 17:25 - 17:30
  
  Popliteal artery lesions: How do I decide between DCB, stenting, atherectomy or bypass
11. 17:30 - 17:35
  
  SuperB trial: a prospective randomized study comparing endoluminal bypass to surgery
12. 17:35 - 18:00
  
  Live case transmission from Kingsport
Thursday, January 28th: 8:00 - 9:30, Room 1 - Main Arena 1

The last frontiers: Retrograde tibial interventions and below-the-ankle angioplasty

Moderator:

Gary Ansel

Panel:

Jihad Mustapha, Kazushi Urasawa, Roberto Ferraresi, Steven Kum, Hiroyoshi Yokoi
1. 08:00 - 08:25
  
  Live case transmission from Leipzig
2. 08:25 - 08:39
  
  THE RETROGRADE TIBIAL PUNCTURE
3. 08:25 - 08:32
  
  Ultrasound guided technique
4. 08:32 - 08:39
  
  Fluoroscopy-guided technique
5. 08:39 - 08:46
  
  The anatomy of pedal vasculature and principles for pedal intervention
6. 08:46 - 09:09
  
  Live case transmission from Abano Terme
7. 09:09 - 09:16
  
  Advanced wiring techniques for below-the-knee and below-the-ankle interventions
8. 09:16 - 09:23
  
  Implications of the wound related artery concept for BTK revascularization strategies: When and how to do pedal interventions?
9. 09:23 - 09:30
  
  Results of 999 BTK angioplasty procedures from a tertiary high-volume diabetic foot center
Thursday, January 28th: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: Advancing DCB therapy in complex SFA lesions

supported with an educational grant from Spectranetics

Moderator:

Craig Walker

Panel:

Henrik Schröder, Erwin Blessing, Fabrizio Fanelli, Eric Dippel
1. 09:30 - 09:38
  
  DCB towards standard of care: Evidence Status of DCBs in SFA
2. 09:38 - 09:46
  
  The when and why of pre-dilatation before DCB: lessons from ILLUMENATE FIH
3. 09:46 - 10:15
  
  Live case transmission from Bad Krozingen
4. 10:15 - 10:23
  
  Plaque scoring in calcified lesions
5. 10:23 - 10:52
  
  Live case transmission from Leipzig
6. 10:52 - 11:00
  
  Photoablation and DCB in in-stent restenosis
Thursday, January 28th: 11:00 - 12:30, Room 1 - Main Arena 1

Symposium: The Lumivascular future: Image-guided therapy with Pantheis and Ocelot

supported with an educational grant from Avinger

Moderator:

Marianne Brodmann

Panel:

Suhail Dohad, Ian Cawich, Jeffrey G. Carr
1. 11:00 - 11:05
  
  Introduction by the moderator
2. 11:05 - 11:15
  
  OCT for peripheral vascular intervention
3. 11:15 - 11:25
  
  Lumivascular case series
4. 11:25 - 11:45
  
  Live case transmission from Münster
5. 11:45 - 11:55
  
  Applying Lumivascular in the office based lab setting
6. 11:55 - 12:05
  
  VISION 6 month data outcomes
7. 12:05 - 12:25
  
  Live case transmission from Münster
8. 12:25 - 12:30
  
  Discussion and conclusion
Thursday, January 28th: 12:30 - 13:25, Room 1 - Main Arena 1

Lunch symposium: Moving the boundaries of BTK treatment

supported with an educational grant from Cook Medical

Panel:

Jihad Mustapha, Yann Gouëffic, Francesco Liistro
1. 12:30 - 12:40
  
  Retrograde first
2. 12:40 - 12:55
  
  Live case transmission from Leipzig: Retrograde tibial puncture step-by-step
3. 12:55 - 13:05
  
  Multidisciplinary approach to BTK
4. 13:05 - 13:15
  
  How far to go to save the diabetic foot
5. 13:15 - 13:25
  
  Wrap-up live case and discussion
Thursday, January 28th: 13:30 - 15:00, Room 1 - Main Arena 1

LINC Expert Course: Pioneering techniques for CLI and CTOs (Part I) - with Marco Manzi live from Abano Terme - with Thomas Zeller live from Bad Krozingen - with Andrej Schmidt live from Leipzig

live:

Marco Manzi, Thomas Zeller, Andrej Schmidt

Moderator:

Marc Bosiers, Stephan Duda

Panel:

Erwin Blessing, Jos van den Berg, Kazushi Urasawa, Steven Kum
1. 13:50 - 13:55
  
  Flash presentation: IVUS-guided DES implantation for treating long SFA-CTOs
2. 14:15 - 14:20
  
  Flash presentation: Update on bi-directional wiring techniques to recanalize long SFA occlusions
3. 14:20 - 14:25
  
  Flash presentation: The Wingman CTO catheter: First experience with a new CTO renanalization needle device
4. 14:50 - 14:55
  
  Flash presentation: Micro-Mesh stent technology – also a solution for peripheral arteries?
5. 14:55 - 15:00
  
  Flash presentation: Treatment of embolic complications in vascular interventions
Thursday, January 28th: 15:00 - 16:30, Room 1 - Main Arena 1

Controversies, challenges and new concepts in renal and visceral interventions and concepts for patients with chronic kidney disease

Moderator:

Ramon Varcoe, Klaus Mathias

Panel:

Kenneth Rosenfield, Dariusz Dudek, Roland E. Schmieder, Felix Mahfoud, Eberhard Wedell, Craig Walker
1. 15:00 - 15:07
  
  Endovascular treatment of renal and visceral aneurysms
2. 15:07 - 15:14
  
  Does no one talk about renal artery stenting anymore?
3. 15:14 - 15:21
  
  The concept of renal artery denervation – dead or alive?
4. 15:21 - 15:38
  
  Live case transmission from Bad Krozingen
5. 15:38 - 15:45
  
  Externally delivered focused ultrasound for renal denervation
6. 15:45 - 15:52
  
  The next step in the interventional treatment of hypertension: SPYRAL HTN global clinical trial program
7. 15:52 - 15:59
  
  Rescue procedures in acute visceral ischemia
8. 15:59 - 16:16
  
  Live case transmission from Teaneck
9. 16:16 - 16:23
  
  Preventing contrast induced nephropathy: Technical solutions, and clinical utility of CO2 angiography
10. 16:23 - 16:30
  
  Contrast saving strategies for BTK recanalisation with the ARROWGPSCath
Thursday, January 28th: 16:30 - 18:00, Room 1 - Main Arena 1

LINC Expert Course: Pioneering techniques for CLI and CTOs (Part II) - with Thomas Zeller live from Bad Krozingen - with John Rundback live from Teaneck

live:

Thomas Zeller, John Rundback

Moderator:

Kenneth Rosenfield, Steven Kum

Panel:

Ralf Langhoff, Jihad Mustapha, Miguel Montero-Baker, Andrej Schmidt, Peter Huppert
1. 16:50 - 16:55
  
  Flash presentation: CTO-crossing based on cap morphology
2. 16:55 - 17:00
  
  Flash presentation: The value of C-arm perfusion CT to validate angiosom-guided revascularization
3. 17:00 - 17:05
  
  Flash presentation: Office based assessment of changes in perfusion after endovascular Interventions in CLI patients with Indocyanin Green angiography
4. 17:25 - 17:30
  
  Flash presentation: Technical overview of percutaneous deep vein arterialisation – The LimFlow procedure
5. 17:30 - 17:35
  
  Flash presentation: Implantable microsensors to measure oxygen saturation: A new approach to assess procedural outcomes?
Friday, January 29th: 9:00 - 12:30, Room 1 - Main Arena 1

Critical issues and pioneering solutions in aortic endografting

Moderator:

Andrea Stella, Martin Malina

Panel:

Thomas Nolte, Roberto Chiesa, Wolfgang Ritter, Thomas Larzon, Frank Criado, Michael Jacobs
1. 09:00 - 09:40
  
  Live case transmission from Münster
2. 09:40 - 09:47
  
  Chimneys and parallel grafts will remain useful for many years to come: Summary of current techniques and results
3. 09:47 - 09:54
  
  Nexus aortic arch stent-graft system: early results of the on-going studies
4. 09:54 - 10:01
  
  Experience with the new Thoraflex graft for aortic arch replacement
5. 10:01 - 10:08
  
  How to overcome obstacles in treating chronic aortic dissections?
6. 10:08 - 10:15
  
  Open and endovascular treatment of Lusorian artery
7. 10:15 - 10:45
  
  Live case transmission from Leipzig
8. 10:45 - 10:52
  
  Challenging endovascular treatment of Lusorian artery PAU
9. 10:52 - 10:59
  
  Minimal invasive segmental artery coil embolization to prevent spinal cord ischemia after EVAR of TAAA
10. 10:59 - 11:06
  
  Homografts for mycotic aneurysms and infected grafts: summary of techniques and outcomes
11. 11:06 - 11:13
  
  Long-term follow-up of semi-conservative treatment of mycotic aneurysms and graft infections: Is radical surgery really justified?
12. 11:13 - 11:20
  
  2 in 1 stentgraft to reduce aortic coverage in T-Branch
13. 11:20 - 12:00
  
  Live case transmission from Münster
14. 12:00 - 12:30
  
  Discussion and conclusion

Notice

LINC 2016 programme

Room 1 - Main Arena 1

Symposium: Treatment strategies for complex disease in the SFA/Pop

Introduction by the moderator and overview of complex SFA disease: calcium, long lesions, reintervention

Treatment strategies for calcium

Treatment strategies for long lesions > 20 cm

Live case transmission from Leipzig

SUPERSUB: Results of subintimal SUPERA cohort in CLI patients

Economic fempop treatment depends on device choice

Treatment strategies for reintervention (catastrophic failure)

Live case transmission from Leipzig

Changing paradigms and future concepts in peripheral interventions – how far have we come?

DRUG-COATED BALLOONS: LATEST DATA FROM CLINICAL TRAILS

Angiographic and clinical 6 months results of the CONSEQUENT trial

AcoArt Trial – 12 months results with the Orchid DEB in femoropoliteal lesions

Latest insights from the LEVANT II study and subgroup analysis

IN.PACT SFA trial – 2 year outcomes

Update on the German/US budget impact model on the cost-effectiveness of DCB in the German & US healthcare systems

DRUG-COATED BALLOONS: ALSO THE PRIMARY SOLUTION FOR LONG LESIONS?

Drug-coated balloons: Also the primary solution for long lesions? Pro:

Drug-coated balloons: Also the primary solution for long lesions? Contra:

Panel discussion

ADJUNCTIVE TREATMENT MODALITIES FOR COMPLEX LESIONS

From pre-dilatation to debulking: what, when and why to add more upon plain DCB

Live case transmission from Leipzig

When DCB is not enough: Is there a need for new DAART study?

FUTURE CONCEPTS FOR DRUG DELIVERY

DANCE trial

THE LATEST IN IMPLANT TECHNOLOGY

Eluvia 12 months data

RAPID trial: A RCT comparing legflow DCB versus POBA followed by SUPERA stenting in “real world” long-segment femoropopliteal lesions

Discussion

Symposium: Drug elution – leave the right thing behind. Debating evidence to provide the answers.

Introduction by the moderator

Why my stent usage is increasing

Surgical bypass or Zilver PTX – 12-month preliminary data

Live case transmission from Leipzig

Leave the right thing behind - patterns of restenosis

Live case transmission from Dendermonde

An evidence based approach: Bare stents and balloons are obsolete

Summary of the symposium, discussion and questions

Lunch

Symposium: From simple to complex lesions: Is the robust IN.PACT DCB evidence shifting the SFA treatment paradigm?

Deep dive: IN.PACT SFA 2 year outcomes

A real-world experience: 12-month outcomes from IN.PACT Global Long Lesions imaging cohort

Live case transmission from Cotignola

The vexing problem of ISR: Is IN.PACT DCB the solution? 12 months outcomes from IN.PACTGlobal study ISR imaging cohort

Understanding the science behind the latest evidence

How IN.PACT DCB evidence has changed my SFA treatment algorithm

Live case transmission from Leipzig

Controversial issues, new insights and pioneering solution for Critical Limb Ischemia

First-line treatment strategies in patients with critical limb ischemia: One year outcomes from the CRITISCH registry

Explaining the discrepancy between low patency and higher limb salvage rates after revascularization for CLI: Does perfusion matter or not?

CLINICAL TRAIL UPDATE

The 3 year outcomes of endoluminal bypass for patients with CLI: The Spanish experience

The NANOCROSS study: final 12 month results

1-year results of the PES-BTK-70 study: investigating a self-expanding paclitaxel-eluting stent in BTK arteries

12 months results of the PREVENT study: investigating the Everolimus-eluting stent in BTK lesions in CLI patients

Live case transmission from Leipzig

Calcification of BTK arteries: The scope of the problem and attempts to solve it

Bioabsorbable drug-eluting scaffolds in BTK arteries: Update on the ABSORB BTK project

Future concepts for drug delivery

The LIMBO project: Micropuncture mediated adventitial drug infusion to prevent restenosis in BTK arteries

Tack optimized balloon angioplasty below the knee (TOBA-BTK) 6 months results: A new method for treating CLI patients with post-PTA dissections

Remaining challenges and future concepts: Will drug-eluting balloons ever work in BTK arteries? - R. Virmani

The last frontiers: Calcified lesions

Patterns of vessel calcification and clinical relevance

Crossing techniques for calcified CTOs

Live case transmission from New York

WHAT IS THE BEST CONCEPT TO DEAL WITH SEVERE CALCIFICATION?

Remove it! – Update on atherectomy techniques for calcified lesions

Just stent it! – Biomimetic interwoven stents

Disrupt it! – The Shockwave lithotrypsie concept

Go around it! – The percutaneous bypass technique

Recorded case: Shockwave lithotrypsie

Live case transmission from Leipzig

Symposium: The evolution of peripheral arterial interventions and the revolution in drug eluting technologies

Introduction by the moderator

State of play – contemporary use of DCB and Ranger Investigator Sponsored Research